HomeMNOV • NASDAQ
Medicinova Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.20M | 2.12% |
Net income | -2.86M | -3.98% |
Net profit margin | — | — |
Earnings per share | -0.06 | — |
EBITDA | -3.20M | -2.13% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 36.57M | -22.42% |
Total assets | 52.43M | -16.64% |
Total liabilities | 2.50M | -18.37% |
Total equity | 49.93M | — |
Shares outstanding | 49.05M | — |
Price to book | 1.39 | — |
Return on assets | -14.78% | — |
Return on capital | -15.52% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -2.86M | -3.98% |
Cash from operations | -3.78M | 2.19% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -3.79M | 1.87% |
Free cash flow | -2.93M | 4.39% |
Previous close
$1.42
Day range
$1.39 - $1.41
Year range
$1.12 - $2.55
Market cap
68.17M USD
Avg Volume
11.14K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
CEO
Founded
Sep 26, 2000
Headquarters
Website
Employees
13
